ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ODX Omega Diagnostics Group Plc

2.20
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Omega Diagnostics Group Plc LSE:ODX London Ordinary Share GB00B1VCP282 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.20 2.00 2.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Omega Diagnostics Share Discussion Threads

Showing 2926 to 2950 of 37200 messages
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older
DateSubjectAuthorDiscuss
07/3/2019
16:52
Read the latest tweet, article in the Scottish Herald. Statement from Colin King reference turnover...
barrywhit
07/3/2019
14:23
They could be filling an order for the new Non-Exec Director, just surprised the lack of buying after the CD4 update....
barrywhit
07/3/2019
10:26
I am surprised that there are still sellers.. My concern is that this is being manipulated down. I have done a small trade . The price is currently 12 to sell and 13 to buy.

Could be a fund raise on the way. Alternatively a takeover . Which I have mentioned before.

Does anyone have any constructive thoughts on this.

upomega
06/3/2019
09:55
INMO

Excellent news and congratulations to Colin King and his team.

Everything that they have said they would do during the past year has so far materialised .

upomega
06/3/2019
08:45
Not concerned, or surprised, at lack of market reaction thus far. This will be a slow burner now in all likelihood. But I am now bullish again. The worst is over.
dibs61
06/3/2019
08:41
Good to see that they are one step further in Visitect commercialisation. The only note of caution comes with the statement: "As expected by the Company, the order quantities are low at this stage and reflect distributors' intentions to seed their private business-to-business market channels in the initial stages"I might be tempted back soon.I
longshanks
06/3/2019
08:34
Literally, no interest from the market. Shareholders have lost trust in these guys.
likitorma
06/3/2019
07:52
Well if today's news is anything to go by we could be in for some major orders by the end of the year. I certainly think it would be daft to sell at this price at this stage.
arthur_lame_stocks
06/3/2019
07:42
Getting there slowly...
barrywhit
06/3/2019
07:08
Very positive CD4 update! 👏
hyperboreus
05/3/2019
17:10
People seem to be selling despite the recent positive news communicated.I have mentioned this before, but it would be interesting to see how much stock is now held by p,i,s
upomega
04/3/2019
17:18
I understood that we should hopefully have some orders re visetect around now. It was mentioned by the CEO in an article in either the Scotsman or Scotish Herald back in December. So fingers crossed
upomega
04/3/2019
14:46
Hi p1nkfish, very well thanks, hope you and yours are all well.

We could really do with a good bit of news to lift the share price.

barrywhit
01/3/2019
22:00
Hope all is well barry.
Sneller keeping it close, wonder what they could possibly talk about when they meet up at family gatherings.

p1nkfish
01/3/2019
17:01
A few more tweets from omega including this tweet from IDS.

IDS are pleased to announce the launch of the #Allergy panel on the IDS-iSYS Multi-Discipline Automated System. @OmegaDiagnostic, our partner, are developing a range of allergens and have appointed IDS as an exclusive, global distributor.

Also a tweet showing a photo of our new NON-EXEC Director........LOL

barrywhit
01/3/2019
11:17
Yes the pressure is growing to deliver near term shareholder value.

Anyone aware when we might expect to receive WHO approval for Visitect CD4 bulk orders for NGO’s?

dibs61
01/3/2019
08:20
Sneller's boots are getting worryingly close to the board's backside!
likitorma
01/3/2019
08:10
They have been looking for another NON-EXEC Director since before December, it just happens to be Sneller's Brother in Law....LOL
barrywhit
01/3/2019
07:49
Hope they have the stupid pay packages that the board is on in mind. Let's see that trimmed by Sneller's BIL once he is appointed to remuneration board.
likitorma
01/3/2019
07:22
Seems like Sneller has lost trust in the board and parachuted in his sister's partner.
likitorma
01/3/2019
07:19
RNS - New Non Exec Director ....Interesting:

Mr Jeremy Howard Millard, age 47, is the brother-in-law of Richard Sneller, who has a substantial shareholding in the Company.

Lets hope he picks up some stock..

barrywhit
01/3/2019
07:19
Obviously independent then!!!
arthur_lame_stocks
01/3/2019
07:15
Interesting board appointment announced today considering 'Mr Jeremy Howard Millard, age 47, is the brother-in-law of Richard Sneller, who has a substantial shareholding in the Company.'
hyperboreus
01/3/2019
06:52
Bomber, those are quite juicy numbers. The issue is whether the board will actually deliver on the promises. Can buy at bid price (13p) suggesting this has further to fall, unfortunately.
likitorma
27/2/2019
22:40
Thanks bomber
upomega
Chat Pages: Latest  120  119  118  117  116  115  114  113  112  111  110  109  Older

Your Recent History

Delayed Upgrade Clock